Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1CNS 1

Conditions

Melanoma 33Neoplasm Metastasis 3Neoplasms 2Carcinoma, Renal Cell 2Uveal Melanoma 1Sarcoma 1Recurrence 1Oligodendroglioma 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Brain Neoplasms 1Astrocytoma 1

Interventions

tovorafenib 2Paclitaxel 2Carboplatin 2vocimagene amiretrorepvec 1regorafenib 1pembrolizumab 1imetelstat 1entinostat 1cediranib 1carboxyamido-triazole 1aflibercept 1Vinblastine 1Thrombopoietin 1Thalidomide 1Sirolimus 1Quality of Life 1Patient Reported Outcome Measures 1Oxaliplatin 1Nivolumab 1NEO212 1Molecular Diagnostic Techniques 1Irinotecan 1Ipilimumab 1Introns 1Immunotherapy 1Immunologic Techniques 1Ifosfamide 1IFL protocol 1Granulocyte Colony-Stimulating Factor 1Flucytosine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × Introns × Dermatologic × Clear all
NCT00498979 2020-07-24

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Case Comprehensive Cancer Center

Phase 1 Completed
22 enrolled
CNSDermatologicSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Melanoma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡